First-of-its kind FDA approved device designed for simplified, minimally invasive Zone 2 TEVAR procedures. Maximize results without the potential risks and complexity of revascularization.

Himanshu Patel, M.D. and Michael Dake, M.D.

National Principal Investigators Himanshu Patel, M.D. and Michael Dake, M.D. share their perspectives on impact to LSA preservation procedures.

Watch now (6:04) 

doctor showing nurse information on tablet

From pre-case planning to device procedural consultation, we are by your side to provide support. 

    Training needs – Essential technical support with a deep reservoir of product knowledge. 8+ years – Average field representatives’ tenure supporting Gore's aortic devices, building on diverse clinical backgrounds. Non-commissioned sales force – Our focus is on outcomes.

Contact your Gore Field Sales Associate to learn more.

* For patients treated with TBE compared to those treated TEVAR and surgical LSA revascularization

  1. Squiers JJ, DiMaio JM, Schaffer JM, et al. Surgical debranching versus branched endografting in zone 2 thoracic endovascular aortic repair. Journal of Vascular Surgery 2022;75(6):1829-1836.e3.
  2. GORE® TAG® Thoracic Branch Endoprosthesis. [Instructions for Use]. Flagstaff, AZ: W. L. Gore & Associates, Inc. 2022; MD184153. Rev. 1
21274900-EN thumbnail

Basic information about thoracic disease and treatment options for patients and their families

22495265-EN thumbnail

Overview of device, deployment, and primary benefits substantiated by data / outcomes for GORE® TAG® Thoracic Branch Endoprothesis.

Innovating aortic repair. One patient's story.

How branch technology for Zone 2 treatment impacted one patient's life.

eIFU Symbol

INDICATIONS FOR USE IN THE U.S.: The GORE® TAG® Thoracic Branch Endoprosthesis is indicated for endovascular repair of lesions of the descending thoracic aorta, while maintaining flow into the left subclavian artery, in patients who have: Adequate iliac/femoral access; Proximal Aortic Landing Zones: For Isolated Lesion Patients: Proximal landing zone cannot be aneurysmal, dissected, heavily calcified or heavily thrombosed; For Dissection Patients: Primary entry tear must be distal to the left subclavian artery and the proximal extent of the landing zone must not be dissected; Aortic inner diameter range 16-42 mm; Proximal segment length (length from distal edge of left subclavian artery to mid left common carotid ostium) of at least 2.0-4.0 cm, depending on Aortic Component selection; Proximal covered length (measured from distal edge of left subclavian artery to distal edge of left common carotid artery ostium) of at least 15–36 mm, depending on Aortic Component selection; For patients with prior ascending aorta or aortic arch repair with surgical graft: at least 2 cm landing zone proximal to the distal anastomosis; Left Subclavian Landing Zone: Landing zone cannot be aneurysmal, dissected, heavily thrombosed and severely tortuous (180 degree turn within the treated length); Left subclavian artery inner diameter of 6–18 mm, depending on Side Branch Portal diameter selected; Left subclavian artery minimum length of 2.5–3.0 cm, depending on Side Branch Portal diameter selected. Distal Landing Zone (Isolated Lesion Patients only): Outer curve length must be ≥ 2 cm proximal to celiac artery; Aortic inner diameter range 16-42 mm; Non aneurysmal, dissected, heavily calcified or heavily thrombosed landing zone; Native Aorta or previously placed GORE® TAG® Conformable Thoracic Stent Graft. CONTRAINDICATIONS: The GORE® TAG® Thoracic Branch Endoprosthesis is contraindicated in: Patients with known sensitivities or allergies to the device materials [ePTFE (polytetrafluoroethylene), FEP (fluoroethylpropylene), Nitinol (nickel, titanium), Gold, SB Component only - Heparin (CBAS® Heparin Surface)]; Patients who have a condition that threatens to infect the graft; Patients with known hypersensitivity to heparin, including those patients who have had a previous incident of Heparin-Induced Thrombocytopenia (HIT) type II. Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. RXOnly

231140978-EN

GORE® TAG® Thoracic Branch Endoprothesis